Sigal Aviel
Geschäftsführer bei PAINREFORM LTD.
Aktive Positionen von Sigal Aviel
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PAINREFORM LTD. | Geschäftsführer | 01.01.2014 | - |
Karriereverlauf von Sigal Aviel
Ehemalige bekannte Positionen von Sigal Aviel
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MEDIWOUND LTD. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2013 | 12.05.2014 |
Biokine Therapeutics Ltd.
Biokine Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Biokine Therapeutics Ltd. Is a clinical-stage biopharmaceutical company, which engages in the research and development of biotechnologies for the treatment of cancer. It conducts a pre-clinical and clinical drug research that targets the tumor microenvironment of cancer cells. The company was founded by Amnon Peled in 2000 and is headquartered in Rehovot, Israel. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2011 | 01.01.2013 |
General Counsel | 01.01.2011 | 01.01.2013 | |
PROTALIX BIOTHERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2005 | 01.10.2010 |
Ausbildung von Sigal Aviel
Kellogg School of Management | Masters Business Admin |
Duke University School of Medicine | Doctorate Degree |
Tel-Aviv University | Undergraduate Degree |
Statistik
International
Israel | 5 |
Vereinigte Staaten | 4 |
Operativ
Chief Tech/Sci/R&D Officer | 3 |
Chief Operating Officer | 1 |
General Counsel | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
MEDIWOUND LTD. | Health Technology |
PAINREFORM LTD. | Health Technology |
PROTALIX BIOTHERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Biokine Therapeutics Ltd.
Biokine Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Biokine Therapeutics Ltd. Is a clinical-stage biopharmaceutical company, which engages in the research and development of biotechnologies for the treatment of cancer. It conducts a pre-clinical and clinical drug research that targets the tumor microenvironment of cancer cells. The company was founded by Amnon Peled in 2000 and is headquartered in Rehovot, Israel. | Health Technology |
- Börse
- Insiders
- Sigal Aviel
- Erfahrung